Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
about
Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Overexpression of LLT1 (OCIL, ...... T1-NKRP1A (CD161) interaction.
@en
Overexpression of LLT1 (OCIL, ...... T1-NKRP1A (CD161) interaction.
@nl
type
label
Overexpression of LLT1 (OCIL, ...... T1-NKRP1A (CD161) interaction.
@en
Overexpression of LLT1 (OCIL, ...... T1-NKRP1A (CD161) interaction.
@nl
prefLabel
Overexpression of LLT1 (OCIL, ...... T1-NKRP1A (CD161) interaction.
@en
Overexpression of LLT1 (OCIL, ...... T1-NKRP1A (CD161) interaction.
@nl
P2093
P2860
P356
P1433
P1476
Overexpression of LLT1 (OCIL, ...... LT1-NKRP1A (CD161) interaction
@en
P2093
Jamboor K Vishwanatha
Porunelloor A Mathew
Sheila B Powers
Stephen O Mathew
P2860
P304
68650-68661
P356
10.18632/ONCOTARGET.11896
P407
P577
2016-10-01T00:00:00Z